Zepbound (FDA-Approved for Weight Management) Zepbound\u00AE (tirzepatide) injection is an FDA-approved dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly and Company, indicated for chronic weight management in adults with obesity or overweight with at least one weight-related medical condition, used along with a reduced-calorie diet and increased physical activity
Sulfur burps are a side effect of how GLP-1 medications slow gastric emptying, but they're not a direct indicator of weight loss effectiveness
Pharmacol Biochem Behav 2002
A licensed medical provider reviews your evaluation and determines whether participation is clinically appropriate based on your individual health profile
My personal experience with GLP-1s As someone who was given rice cereal solids in my bottle as an infant, because I was insatiable, I yo-yo dieted during puberty and was sent to fat camp over multiple summers
A large extension study involving semaglutide found that participants who stopped after 68 weeks regained a substantial proportion of their lost weight over the following 12 months